Nicolau syndrome following subcutaneous glatiramer acetate injection: A case report and review of the literature.

Indian J Pharmacol

Department of Dermatology and Venereology, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey.

Published: February 2022

Nicolau syndrome is a rare serious drug reaction associated with the administering various injectable medications. It is often characterized by an acute and severe pain accompanying erythema that tends to rapidly evolve into the livedoid reticular or hemorrhagic patches and less commonly to ulcers and skin necrosis. Herein, we report a 34-year-old woman who presented with painful, tender discoloration over her abdominal skin following subcutaneous glatiramer acetate injection. Since the patient was diagnosed with multiple sclerosis 18 months ago, she had been on treatment with subcutaneous glatiramer acetate injections thrice weekly. The patient was diagnosed with Nicolau syndrome clinically and histopathologically. After 15-day treatment with topical betamethasone valerate and mucopolysaccharide polysulfate cream twice daily, the lesion completely regressed with only minimal hypopigmented irregular scarring. Nicolau syndrome should be considered in patients with severe pain, tenderness, and redness localized at the injection site following glatiramer subacetate.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764978PMC
http://dx.doi.org/10.4103/ijp.ijp_166_21DOI Listing

Publication Analysis

Top Keywords

nicolau syndrome
16
subcutaneous glatiramer
12
glatiramer acetate
12
acetate injection
8
severe pain
8
patient diagnosed
8
nicolau
4
syndrome subcutaneous
4
glatiramer
4
injection case
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!